Hitomi Sezaki
6PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Oct 23, 2021
Renal safety and biochemical changes for 2 years after switching to tenofovir alafenamide from long-term other nucleotide analog treatment in patients with chronic hepatitis B.Tetsuya Hosaka, Fumitaka Suzuki, Masahiro Kobayashi
|Sep 17, 2021
Ultrasensitive Assay for Hepatitis B Core-Related Antigen Predicts Hepatocellular Carcinoma Incidences During Entecavir.Tetsuya Hosaka, Fumitaka Suzuki, Mariko Kobayashi
|Jan 08, 2020
Circulating MicroRNA-122 and Fibrosis Stage Predict Mortality of Japanese Patients With Histopathologically Confirmed NAFLD.Norio Akuta, Yusuke Kawamura, Yasuji Arase
|Jul 27, 2019
Real-world effects of long-term rifaximin treatment for Japanese patients with hepatic encephalopathy.Hiroyuki Suzuki, Hitomi Sezaki, Fumitaka Suzuki
|Mar 24, 2019
Initial- and re-treatment effectiveness of glecaprevir and pibrentasvir for Japanese patients with chronic hepatitis C virus-genotype 1/2/3 infections.Hitomi Sezaki, Fumitaka Suzuki, Tetsuya Hosaka
|Feb 09, 2017
The efficacy and safety of dual oral therapy with daclatasvir and asunaprevir for genotype 1b in Japanese real-life settings.Hitomi Sezaki, Fumitaka Suzuki, Tetsuya Hosaka
Pageof 1
